The use of sertraline to treat post myocardial infarction...

Details The use of sertraline to treat post myocardial infarction... The use of sertraline to treat post myocardial infarction...

A - Human Necessities

61

K

A61K 31/135 (2006.01)

Patent

CA 2181225

Disclosed is a pharmaceutical composition for treating post myocardial infarction human patients comprising the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydro-N-methyl-1-naphthalenamine, also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof.

Divulgation concernant une composition pharmaceutique pour le traitement de l'infarctus du myocarde chez l'homme, renfermant le composé (1S-cis)-4-(3,4-dichlorophényl)-1,2,3,4- tétrahydro-N-méthyl-1-naphtalène-amine, également connu sous le nom commun de sertraline, ou un sel pharmacocompatible de ce composé.

Affiliated with

Also associated with

Rating

The use of sertraline to treat post myocardial infarction... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of sertraline to treat post myocardial infarction..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of sertraline to treat post myocardial infarction... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1421037